O’Melveny & Myers represented Nkarta, Inc. in the offering, and Shearman & Sterling represented the underwriters. Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural...
Nkarta’s $240 Million Common Stock Offering
Nkarta’s $230 Million Common Stock Offering
O’Melveny & Myers represented Nkarta, while Shearman & Sterling represented Cowen and Company, LLC, SVB Securities LLC and Evercore Group L.L.C., as representatives of the underwriters,...
Amgen’s $5 Billion Notes Offering
Shearman & Sterling represented the joint book-running managers and representatives of the underwriters in the offering. Amgen’s registered $5 billion notes offering, consisting of 1.650 percent...
Build Acquisition’s $200 Million Initial Public Offering
Shearman & Sterling advised Build Acquisition Corp. on the deal. Build Acquisition Corp., a special-purpose acquisition company, executed its initial public offering of 20 million units at...